FDA considers an independent body to monitor tobacco research

Thomson Reuters

By Jacob Hale Russell

(Reuters) – The Federal Drug Administration is considering a recommendation that an independent body should monitor some research put to the agency by tobacco companies, underscoring the growing concern about conflicts of interest in scientific research.

The recommendation was submitted by the Institute of Medicine, a scientific research organization that’s part of the National Academy of Sciences, and is based on its 2011 report. It suggests that any research provided to the FDA by manufacturers of so-called modified-risk tobacco products, which companies want to market as “less” risky, should be overseen by an independent body.

Big Tobacco Companies Breathing Sigh of Relief After FDA Drops Graphic Warning Labels for Cigarettes

Fox  News


Big tobacco companies are breathing a sigh of relief Friday morning.

The Food and Drug Administration (FDA) has scrapped a series of graphic warning labels for cigarettes.

It’s decided not to challenge a court ruling which said the shocking images violated free speech protections.

Attorney General Eric Holder says the FDA will propose new labels. However, that could take a few years.

FDA weighs tobacco company proposals

The Hill

By Ben Goad

The Food and Drug Administration (FDA) is considerating of a series of year-old regulatory recommendations issued by a coalition of tobacco companies. 

Beginning Tuesday, interested parties and members of the public will have 60 days to consider the proposal submitted to FDA in January of last year.  The recommendations relate to manufacturing practices and the industry’s interpretation of existing regulations, according to a notice to be published in the federal register.

A docket will be created for comments and related materials, including the proposal, here.

FDA’s New Tobacco Scheme, and its Legislative Underpinnings, May Go Up in Smoke

Editor’s Note:  The author of the following article concludes:

“The FDA has done an admirable job – to date – resisting the entreaties of anti-tobacco protesters to use the legislation as a vehicle for a full on assault on cigarette makers.”

We agree and suggest that all stakeholders express their support for FDA’s insistence on basing decisions on sound science. However  CRE is very concerned  about the following statement:

” Activists have managed to infiltrate the middle ranks of the agency’s center

BAT Says New ‘Safe’ Nicotine Product May Be Ready by 2014


British American Tobacco Plc (BATS) said it may sell an alternative nicotine product in the U.K. as early as next year, as Europe’s largest cigarette maker moves to counter stricter global restrictions on smoking.

The maker of Lucky Strikes is expecting approval for a new “tobacco inhalation device” that is not an electronic cigarette by the end of this year and it could be “ready to launch some time in 2014, if not, 2015,” Kingsley Wheaton, BAT’s director of corporate and regulatory affairs, said in a telephone interview today.